Preclinical Data on New Pancreatic Cancer Drug Shines with over 90% Efficacy
BioSpace
JULY 19, 2021
Preclinical data for its drug candidate, LP-184, reportedly showed over 90 percent efficacy in shrinking pancreatic cancer tumors in mouse models in vitro, in-vivo, and ex-vivo.
Let's personalize your content